According to GEPIA and Seifert et al., there is also elevated expression of ACOT9 in GBM tumors [8,9], an enzyme showing the highest activity to myristoyl-CoA [69,70,72] and low activity to longer acyl-CoA. This evidence concerns the gene ACOT9 and glioblastoma.